Efficacy of high-intensity focused ultrasound cycloplasty in glaucoma and its influencing factor
10.3980/j.issn.1672-5123.2024.4.23
- VernacularTitle:高能聚焦超声睫状体成形术治疗青光眼的疗效及其影响因素
- Author:
Yurong TANG
1
;
Fuhua LI
1
;
Xiangge HE
1
;
Xiaohong ZHOU
1
;
Yi ZHOU
1
;
Wei WANG
1
Author Information
1. Chongqing Nanping Aier Eye Hospital, Chongqing 400060, China
- Publication Type:Journal Article
- Keywords:
high-intensity focused ultrasound ciliary plasty;
glaucoma;
efficacy;
influencing factors
- From:
International Eye Science
2024;24(4):618-622
- CountryChina
- Language:Chinese
-
Abstract:
AIM: To evaluate the efficacy of high-intensity focused ultrasound cyclo plasty(UCP)in the treatment of glaucoma and to investigate related influencing factors.METHODS: The study involved a total of 110 patients(134 eyes)who received UCP treatment between January 2019 and January 2022 at three medical centers: Tianjin Eye Aier Eye Hospital, Chongqing Aier Eye Hospital, and Chongqing Nanping Aier Eye Hospital. Patients were classified into three categories: primary angle-closure glaucoma, primary open-angle glaucoma, and secondary glaucoma. Best corrected visual acuity, intraocular pressure, and the usage of anti-glaucoma medications, etc., were recorded at 6 and 12 mo postoperatively.RESULTS: After 6 months of the UCP procedure, statistically significant differences in intraocular pressure were observed across all groups(all P<0.05). At 12 mo postoperatively, intraocular pressure of the primary angle-closure and primary open-angle glaucoma groups showed differences(all P<0.05). Notably, there were no significant changes in visual acuity at either the 6 or 12 mo compared to preoperative values across all patient groups(all P>0.05). Furthermore, the study identified a statistically significant correlation between the changes in intraocular pressure at 6 mo and factors such as age, history of previous glaucoma surgery, baseline white-to-white(corneal diameter), and the extent of UCP treatment(all P<0.05).CONCLUSION: The UCP procedure has been demonstrated to effectively lower intraocular pressure in patients with glaucoma. The efficacy appears to be influenced by variables including patient age, previous glaucoma surgery history, baseline white-to-white(corneal diameter), and the scope of UCP treatment. Importantly, UCP treatment did not adversely affect visual acuity, underscoring its favorable safety profile.
